IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

MicroRNAs in Diffuse Large B-Cell Lymphoma: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. K. TROPPAN, K. WENZL, A. DEUTSCH, H. LING, P. NEUMEISTER, M. PICHLER (Graz, Austria; Houston, TX, USA). Anticancer Res 34: 557-564. 2014
‘BRCAness’ and Its Implications for Platinum Action in Gynecologic Cancer. F. MUGGIA, T. SAFRA (New York, NY, USA; Tel Aviv, Israel). Anticancer Res 34: 551-556. 2014
Counseling Patients on Cancer Diets: A Review of the Literature and Recommendations for Clinical Practice. J. HUEBNER, S. MARIENFELD, C. ABBENHARDT, C. ULRICH, K. MUENSTEDT, O. MICKE, R. MUECKE, C. LOESER (Frankfurt am Main; Heidelberg; Gießen; Bielefeld; Bochum; Kassel, Germany). Anticancer Res 34: 39-48. 2014
The Key Role of Bisphosphonates in the Supportive Care of Cancer Patients. M. TOLIA, A. ZYGOGIANNI, J.R KOUVARIS, C. MERISTOUDIS, N. MARGARI, P. KARAKITSOS, I. KOKAKIS, D. KARDAMAKIS, C. PAPADIMITRIOU, K. MYSTAKIDOU, N. TSOUKALAS, G. KYRGIAS, B. ARMONIS, D.K. FILIPPIADIS, A.D. KELEKIS, N. KELEKIS, V. KOULOULIAS (Athens; Patras; Larissa, Greece). Anticancer Res 34: 23-37. 2014
Nutrition and Pancreatic Cancer. M. PERICLEOUS, R.E. ROSSI, D. MANDAIR, T. WHYAND, M.E. CAPLIN (London, UK; Milan, Italy). Anticancer Res 34: 9-21. 2014
The Interaction Between DAP1 and Autophagy in the Context of Human Carcinogenesis. U. WAZIR, Z.S. KHANZADA, W.G. JIANG, A.K. SHARMA, A. KASEM, K. MOKBEL (London; Cardiff, Wales, UK). Anticancer Res 34: 1-8. 2014
Delivery Approaches of Gene Therapy in Hepatocellular Carcinoma.
F. DUAN, M.G.E.H. LAM (Beijing, China; Utrecht, Netherlands). Anticancer Res 33: 4711. 2013
State of the Art in the Treatment of Laryngeal Cancer.
F. JENCKE, R. KNECHT (Hamburg, Germany). Anticancer Res 33: 4701. 2013
Therapeutic Value of Quinazoline-based Compounds in Prostate Cancer.
J. BILBRO, M. MART, N. KYPRIANOU (Lexington, KY, USA). Anticancer Res 33: 4695. 2013
The Paradox of the Unfolded Protein Response in Cancer.
Y.-P. VANDEWYNCKEL, D. LAUKENS, A. GEERTS, E. BOGAERTS, A. PARIDAENS, X. VERHELST, S. JANSSENS, F. HEINDRYCKX, H. VAN VLIERBERGHE (Ghent, Belgium; Uppsala, Sweden). Anticancer Res 33: 4683. 2013
Saving Ears and Kidneys from Cisplatin.
K.U. WENSING, G. CIARIMBOLI (Münster, Germany). Anticancer Res 33: 4183. 2013
Musculoskeletal Sarcomas in the Forearm and Hand: Standard Treatment and Microsurgical Reconstruction for Limb Salvage.
K. MURAMATSU, K. IHARA, K. YOSHIDA, Y. TOMINAGA, T. HASHIMOTO, T. TAGUCHI (Ube; Shimonoseki, Yamaguchi, Japan). Anticancer Res 33: 4175. 2013
Chemoprevention of Prostate Cancer by Major Dietary Phytochemicals.
A. BOMMAREDDY, W. EGGLESTON, S. PRELEWICZ, A. ANTAL, Z. WITCZAK, D.F. MCCUNE, A.L. VANWERT (Wilkes-Barre, PA, USA). Anticancer Res 33: 4163. 2013
Epidermal Growth Factor Receptor (EGFR)-targeted Therapies in Esophagogastric Cancer.
S. AYYAPPAN, D. PRABHAKAR, N. SHARMA (Cleveland, OH, USA). Anticancer Res 33: 4139. 2013
The Value of Pemetrexed for the Treatment of Malignant Pleural Mesothelioma: A Comprehensive Review.
C. C.L.M. BOONS, M. W. VAN TULDER, J. A. BURGERS, J. J. BECKERINGH, C. WAGNER, J. G. HUGTENBURG (Amsterdam; Amstelveen; Utrecht, the Netherlands). Anticancer Res 33: 3553. 2013
Mitochondrial DNA Damage Is Uncommon in Cancer but Can Promote Aggressive Behaviour.
B. D. MAYBURY (Cardiff, U.K. ). Anticancer Res 33: 3543. 2013
Ubiquitination and the Ubiquitin – Proteasome System in the Pathogenesis and Treatment of Squamous Head and Neck Carcinoma.
I. A. VOUTSADAKIS (Sault Ste Marie, Canada). Anticancer Res 33: 3527. 2013
DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer.
A. GNYSZKA, Z. JASTRZĘBSKI, S. FLIS (Warsaw, Poland). Anticancer Res 33: 2989. 2013
Antineoplastic Activity of Zoledronic Acid and Denosumab.
P. ZWOLAK, A.Z. DUDEK (Chicago, IL, USA). Anticancer Res 33: 2981. 2013
Possible Therapeutic Targets Among the Molecules Involved in the Warburg Effect in Tumor Cells.
S. O. NAM, F. YOTSUMOTO, K. MIYATA, N. SHIRASU, S. MIYAMOTO, M. KUROKI (Fukuoka, Japan). Anticancer Res 33: 2855. 2013
Effects of Interactions between Intestinal Microbiota and Intestinal Macrophages on Health.
K. NAKATA, M. YAMAMOTO, H. INAGAWA, G. -I. SOMA (Soja; Kagawa; Tokushima, Japan). Anticancer Res 33: 2849. 2013
Lymph Node Evaluation and Survival in Colorectal Cancer: Review of Population-based, Prospective Studies.
Y. AKAGI, Y. ADACHI, T. KINUGASA, Y. OKA, T. MIZOBE, K. SHIROUZU (Fukuoka, Japan). Anticancer Res 33: 2839. 2013
Roles of ZFAT in Haematopoiesis, Angiogenesis and Cancer Development.
T. TSUNODA, S. SHIRASAWA (Fukuoka, Japan). Anticancer Res 33: 2833. 2013
Tumor-targeted Photodynamic Therapy.
N. SHIRASU, S. O. NAM, M. KUROKI (Fukuoka, Japan). Anticancer Res 33: 2823. 2013
Novel Curcumin Oral Delivery Systems.
T. KURITA, Y. MAKINO (Kagawa; Noda, Japan). Anticancer Res 33: 2807. 2013
Is there a Benefit from Addiction to Anti-VEGF Therapy in Patients with Colorectal Cancer?
M.W. SAIF(Boston, MA, USA). Anticancer Res 33: 2377. 2013
Endoscopic and Endobronchial Ultrasound-guided Needle Aspiration in the Mediastinal Staging of Non-small Cell Lung Cancer.
T. RAPTAKIS, P. BOURA, S. TSIMPOUKIS, I. GKIOZOS, K.N. SYRIGOS (Ierapetra; Athens, Greece). Anticancer Res 33: 2369. 2013
Inguinal Canal Tumors of Adulthood.
V. VAGNONI, E. BRUNOCILLA, R. SCHIAVINA, M. BORGHESI, G. PASSARETTI, G. GENTILE, M. FIORENTINO, G. MARTORANA (Bologna, Italy). Anticancer Res 33: 2361. 2013
Junctional Adhesion Molecules in Cerebral Endothelial Tight Junction and Brain Metastasis.
W. JIA, T.A. MARTIN, G. ZHANG, W.G. JIANG (Beijing, PR China; Cardiff, UK). Anticancer Res 33: 2353. 2013
Denosumab and Anti-angiogenetic Drug-related Osteonecrosis of the Jaw: An Uncommon but Potentially Severe Disease.
S. SIVOLELLA, F. LUMACHI, E. STELLINI, L. FAVERO (Padova, Italy). Anticancer Res 33: 1793. 2013
Current Status in Chemotherapy for Advanced Pancreatic Adenocarcinoma.
H. CAO, D. LE, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 33: 1785. 2013
In Vitro and In Vivo Experimental Models as Tools to Investigate the Efficacy of Antineoplastic Drugs on Urinary Bladder Cancer.
R. ARANTES-RODRIGUES, A. COLAÇO, R. PINTO-LEITE, P.A. OLIVEIRA (Vila Real, Portugal). Anticancer Res 33: 1273. 2013
The Influence of Glutamate Receptors on Proliferation and Metabolic Cell Activity of Neuroendocrine Tumors.
H.S. HAAS, R. PFRAGNER, N.G. TABRIZI-WIZSY, K. ROHRER, I. LUEFTENEGGER,C. HORWATH, N. ALLARD, B. RINNER, A. SADJAK (Graz, Austria). Anticancer Res 33: 1267. 2013
A Review on Biomarkers for Prediction of Treatment Outcome in Gastric Cancer.
F. PIETRANTONIO, F. DE BRAUD, V. DA PRAT, F. PERRONE, M.A. PIEROTTI, M. GARIBOLDI, G. FANETTI,P. BIONDANI, A. PELLEGRINELLI, I. BOSSI, M. DI BARTOLOMEO (Milan, Italy). Anticancer Res 33: 1257.2013
Aryl Hydrocarbon Receptor and Lung Cancer.
J.J. TSAY, K.-M. TCHOU-WONG, A.K. GREENBERG, H. PASS, W.N. ROM (New York, NY, USA). Anticancer Res 33: 1247. 2013
Radiotherapy Targeting Cancer Stem Cells: Current Views and Future Perspectives.
K. OGAWA, Y. YOSHIOKA, F. ISOHASHI, Y. SEO, K. YOSHIDA, H. YAMAZAKI (Osaka; Kyoto, Japan). Anticancer Res 33: 747. 2013
Genistein and Daidzein: Different Molecular Effects on Prostate Cancer.
M. ADJAKLY, M. NGOLLO, J.-P. BOITEUX, Y.-J. BIGNON, L. GUY, D. BERNARD-GALLON (Clermont-Ferrand, France). Anticancer Res 33: 39. 2013
Vaginal Intraepithelial Neoplasia: A Therapeutical Dilemma.
A. FREGA, F. SOPRACORDEVOLE, C. ASSORGI, D. LOMBARDI, V. DE SANCTIS, A. CATALANO, E. MATTEUCCI, G.N. MILAZZO, E. RICCIARDI, M. MOSCARINI (Rome; Aviano, Italy). Anticancer Res 33: 29. 2013
The Mammalian Target of Rapamycin Inhibitors in Breast Cancer: Current Evidence and Future Directions.
P. MALAGUTI, S. VARI, F. COGNETTI, A. FABI (Rome, Italy). Anticancer Res 33: 21. 2013
Anticancer Efficacy of the Metabolic Blocker 3-Bromopyruvate: Specific Molecular Targeting.
S. GANAPATHY-KANNIAPPAN, R. KUNJITHAPATHAM, J.-F. GESCHWIND (Baltimore, MD, USA). Anticancer Res 33: 33. 2013
Neurofibromatosis Type 2 Protein, NF2: An Uncoventional Cell Cycle Regulator.
S. BELTRAMI, R. KIM, J. GORDON (Philadelphia, PA, USA). Anticancer Res 33: 1.2013). Anticancer Res 33: 1. 2013
HSP-Molecular Chaperones in Cancer Biogenesis and Tumor Therapy: An Overview.
F. RAPPA, F. FARINA, G. ZUMMO, S. DAVID, C. CAMPANELLA, F. CARINI, G. TOMASELLO, P. DAMIANI, F. CAPPELLO, E.C. DE MACARIO, A.J.L. MACARIO (Palermo, Italy; Baltimore, MD, USA). Anticancer Res 32: 5139
Recent Trends in Epidemiology of Brain Metastases: An Overview.
E. TABOURET, O. CHINOT, P.METELLUS, A. TALLET, P. VIENS, A. GONÇALVES (Marseille, France). Anticancer Res 32: 4655
Biomarkers of Pituitary Neoplasms.
A. SAV, F. ROTONDO, L.V. SYRO, B.W. SCHEITHAUER, K. KOVACS (Istanbul, Turkey; Toronto, ON, Canada; Medellin, Colombia; Rochester, MN, USA). Anticancer Res 32: 4639
Utility of Hypertension as a Surrogate Marker for Efficacy of Antiangiogenic Therapy in NSCLC.
T. EVANS (Philadelphia, PA, USA). Anticancer Res 32: 4629
Mind the Gap; Regulation of Gap Junctional, Intercellular Communication by the Src OncogeneProduct and its Effectors.
M. GELETU, A. TROTMAN-GRANT, L. RAPTIS (Kingston, ON,Canada). Anticancer Res 32: 4245
Markers for Efficacy of Mammalian Target of Rapamycin Inhibitor.
Y.-M. LIAO, A. SY, Y. YEN (Taichung; * Taipei, Taiwan, ROC; Duarte, CA, USA). Anticancer Res 32: 4235
Regulation of Cancer Cell Survival by BCL2 Family Members upon Prolonged Mitotic Arrest: Opportunities * for Anticancer Therapy.
S. BARILLÉ-NION, N. BAH, E. VÉQUAUD, P. JUIN (Nantes; Saint Herblain-Nantes, France). Anticancer Res 32: 4225
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma:
A Brief Overview of Current Clinical Results. C. SCARINGI, G. MINNITI, P. CAPORELLO, R.M. ENRICI (Rome; Pozzilli, Italy). Anticancer Res 32: 4213
Viral and Molecular Aspects of Oral Cancer.
N.S. HILLBERTZ, J.-M. HIRSCH, J. JALOULI, M.M. JALOULI, L. SAND (Uppsala, Sweden). Anticancer Res 32: 4201
Page: 1 2 3 4 5 6 7 ... 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system